PUBLISHER: TechNavio | PRODUCT CODE: 1093715
PUBLISHER: TechNavio | PRODUCT CODE: 1093715
Technavio has been monitoring the cardiac prosthetic devices market and it is poised to grow by $ 5.87 billion during 2022-2026, accelerating at a CAGR of 8.02% during the forecast period. Our report on the cardiac prosthetic devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of cardiac disorders, a paradigm shift toward MI procedures, and the higher adoption of cardiac prosthetic devices.
The cardiac prosthetic devices market analysis includes product segment and geographic landscape.
Technavio's cardiac prosthetic devices market is segmented as below:
By Product
By Geographical Landscape
This study identifies the advances in technology as one of the prime reasons driving the cardiac prosthetic devices market growth during the next few years. Also, new product launches coupled with R & D activities and the emergence of MRI conditional pacemakers and heart valves will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the cardiac prosthetic devices market covers the following areas:
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cardiac prosthetic devices market vendors that include Abbott Laboratories, Anteris Technologies Ltd., BIOTRONIK SE, and Co KG, Boston Scientific Corp., Braile Biomedica, Colibri Heart Valve LLC, Cryolife Inc., Edwards Lifesciences Corp., Jc Medical Inc., JenaValve Technology Inc., Lepu Medical Technology Beijing Co. Ltd., LivaNova Plc, Medtronic Plc, Meril Life Sciences Pvt. Ltd., Merit Medical Systems Inc., MicroPort Scientific Corp., OrbusNeich Medical Co. Ltd., Shree Pacetronix Ltd., TTK Healthcare Ltd., and Venus Medtech Hangzhou Inc. Also, the cardiac prosthetic devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Exhibits: